Minnesota SF2071 prohibits health plans from using step therapy protocols for prescription insulin drugs.
Minnesota SF2071 amends state statutes to prohibit health plans that cover diabetes treatment from using step therapy protocols for prescription insulin drugs. Step therapy protocols require patients to try other drugs before using the prescribed insulin. The bill also outlines procedures for prior authorization of certain drugs and sets criteria for the commissioner to follow when requiring prior authorization. This law takes effect January 1, 2027.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.